NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-195-2005-1-US-01 NANOPROBES FOR DETECTION OR MODIFICATION OF MOLECULES US CIP 13/732,029 8703734 Abandoned PDF
NCATS E-043-2013-0-US-01 Inhibitors Of The USP1/UAF1 Deubiquitinase Complex And Uses Thereof US 61/747,052 Abandoned
NHLBI E-017-2012-0-PCT-02 Methods Of Treating Or Preventing Viral Disease By Blocking Interleukin-21 PCT PCT PCT/US2012/071173 Expired
NCI E-128-2012-0-US-01 NIK Inhibitors That Selectively Target NIK-Dependent B-Cell Lymphoma US 61/745,422 Abandoned
NINDS E-143-2002-0-US-11 Zenapax (Humanized Antibody Against the IL-2 Receptor Alpha Chain) As A Novel Treatment for Multiple Sclerosis US CON 13/725,119 Abandoned
NCI E-286-2007-0-US-03 Methods for Increasing Levels of Human Fetal Hemoglobin US CON 13/722,995 Abandoned
NIAID E-159-2007-3-US-04 Monoclonal Antibodies Against Dengue And Other Viruses With Deletion IN FC Region US DIV 13/722,275 Abandoned
NCI E-167-2010-0-US-04 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling US National Stage 13/697,259 9475839 Issued PDF
NCI E-203-2011-1-US-02 Discovery Of Novel Inhibitors Of DNA Topoisomerase That Can Be Used For Studying Topoisomerase Functions And For The Treatment Of Human Cancers US National Stage 13/698,739 9181193 Abandoned PDF
NCI E-100-2010-0-US-03 Regulation Of Skin Pigmentation By Neuregulin-I (NRG-1) US National Stage 13/805,638 9168297 Abandoned PDF
NEI E-092-2010-0-US-06 Methods of Treatment Using Sterculic Acid US National Stage 13/805,429 8993626 Abandoned PDF
NCATS E-276-2011-0-CA-04 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis CA National Stage 2859370 Issued
NCATS E-276-2011-0-IT-15 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis IT EP 12806846.7 Issued
NCATS E-276-2011-0-FR-13 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis FR EP 12806846.7 Issued
NCATS E-276-2011-0-DE-11 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis DE EP 12806846.7 Issued
NCATS E-276-2011-0-TR-16 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis TR EP 12806846.7 Issued
NCATS E-276-2011-0-ES-12 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis ES EP 12806846.7 Issued
NCATS E-276-2011-0-GB-14 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis GB EP 12806846.7 Issued
NCATS E-276-2011-0-EP-05 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis EP National Stage 12806846.7 Issued
NCATS E-276-2011-0-AU-03 Compounds And Methods For The Prevention And Treatment Of Tumor Metastasis And Tumorgenesis AU National Stage 2012353651 Issued
NIAID E-279-2011-0-US-02 Methods of Producing T Cell Populations Enriched for Stable Regulatory T-Cells US ORD 13/716,900 9481866 Issued PDF
NCATS E-276-2011-0-PCT-02 Compounds And Methods For The Prevention And Treatment Of Metastasis And Tumorgenesis PCT PCT PCT/US2012/070155 Expired
NCI E-183-2010-0-US-07 Compositions And Methods For Treating Inflammatory Conditions US National Stage 13/704,956 Abandoned
NIDCR E-109-2000-0-US-05 Selective Ablation of Pain-Sensing Neurons By Administration of A Vanilloid Receptor Agonist US CON 13/717,509 Abandoned
NICHD E-302-2011-0-PCT-02 Identification Of Two Novel Biomarkers For Niemann-Pick Disease Type C PCT PCT PCT/US2012/069955 Expired
NIAID E-240-2012-1-PCT-01 CD-4 Mimetic Inhibitors Of HIV Entry And Methods Of Use Thereof PCT PCT COMB PCT/US2012/069708 Expired
NICHD E-302-2011-0-EP-05 Identification Of Two Novel Biomarkers For Niemann-Pick Disease Type C EP National Stage 12857972.9 Abandoned
NICHD E-302-2011-0-AU-03 Identification Of Two Novel Biomarkers For Niemann-Pick Disease Type C AU National Stage 2012351963 Abandoned
NICHD E-302-2011-0-CA-04 Identification Of Two Novel Biomarkers For Niemann-Pick Disease Type C CA National Stage 2859202 Abandoned
NCI E-074-2007-0-AU-12 BRACHYURY POLYPEPTIDES AND METHODS FOR USE AU DIV 2012261687 Issued
NHGRI E-096-2013-0-US-01 METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY MLL FUSION PROTEINS US 61/736,459 Abandoned
NIAID E-067-2012-0-US-01 HIV NEUTRALIZING PEPTIDES AND METHODS OF THEIR USE US 61/736,350 Abandoned
NIAID E-122-2001-0-US-10 Anti-Arthropod Vector Vaccines, Methods of Selecting and Uses Thereof US DIV 13/711,167 8629260 Expired PDF
NCI E-086-2012-1-US-01 Methods For Generation Of Pluripotent and Multipotent Cells US 61/735,701 Abandoned
NIAID E-051-2012-3-CA-02 Neutralizing Antibodies To HIV-1 and Their Use CA National Stage 2858716 Issued
NIAID E-051-2012-3-IN-05 NEUTRALIZING ANTIBODIES TO HIV 1 AND THEIR USE IN National Stage 4661/DELNP/2014 Issued
NIAID E-051-2012-3-ZA-07 Neutralizing Antibodies To HIV-1 and Their Use ZA National Stage 2014/04077 Issued
NIAID E-051-2012-3-BE-12 Neutralizing Antibodies To HIV-1 and Their Use BE EP 12855597.6 Issued
NIAID E-051-2012-3-IE-17 Neutralizing Antibodies To HIV-1 and Their Use IE EP 12855597.6 Issued
NIAID E-051-2012-3-IT-18 Neutralizing Antibodies To HIV-1 and Their Use IT EP 12855597.6 Issued
NIAID E-051-2012-3-DE-14 Neutralizing Antibodies To HIV-1 and Their Use DE EP 12855597.6 Issued
NIAID E-051-2012-3-FR-15 Neutralizing Antibodies To HIV-1 and Their Use FR EP 12855597.6 Issued
NIAID E-051-2012-3-GB-16 Neutralizing Antibodies To HIV-1 and Their Use GB EP 12855597.6 Issued
NIAID E-051-2012-3-CH-13 Neutralizing Antibodies To HIV-1 and Their Use CH EP 12855597.6 Issued
NIAID E-051-2012-3-EP-04 Neutralizing Antibodies To HIV-1 and Their Use EP National Stage 12855597.6 Issued
NIAID E-051-2012-3-CN-03 Neutralizing Antibodies To HIV-1 and Their Use CN National Stage 201280069415.3 Issued
NIAID E-051-2012-3-AU-08 Neutralizing Antibodies To HIV-1 and Their Use AU National Stage 2012347453 Issued
NCI E-257-2009-1-HK-08 Use Of IL-15 To Increase Thymic Output and to Treat Lymphopenia HK EP 12112742.2 Issued
NIAID E-051-2012-3-PCT-01 Neutralizing Antibodies To HIV-1 and Their Use PCT PCT PCT/US2012/068827 Expired
NIDDK E-177-2010-0-US-04 Thioether Prodrug Compositions As Anti-HIV And Anti-retroviral Agents US National Stage 13/703,097 Abandoned